Sicilian pistachio (Pistacia vera L.) nut inhibits expression and release of inflammatory mediators and reverts the increase of paracellular permeability in IL-1β-exposed human intestinal epithelial cells

European Journal of Nutrition

Volumn 54, Issue 5, 2015, Pages 811-821

  Gentile, C ^a   Perrone, A ^a   Attanzio, A ^a   Tesoriere, L ^a   Livrea, M A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Inflammation; Intestinal epithelium; Pistachio nut; Polyphenols; Proanthocyanidins

Indexed keywords

BETA ACTIN; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLYMER; PROANTHOCYANIDIN DERIVATIVE; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR RELA; ANTIINFLAMMATORY AGENT; PROANTHOCYANIDIN; PTGS2 PROTEIN, HUMAN;

ADSORPTION; ARTICLE; CACO 2 CELL LINE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INTESTINE EPITHELIUM CELL; ITALY; MEDIATOR RELEASE; MONOLAYER CULTURE; NONHUMAN; PISTACHIO; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSEPITHELIAL ELECTRICAL RESISTANCE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; INTESTINE; METABOLISM; NUT; PERMEABILITY; PISTACIA;

PISTACIA VERA;

ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; CELL PROLIFERATION; CYCLOOXYGENASE 2; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINES; NF-KAPPA B; NUTS; PERMEABILITY; PISTACIA; PROANTHOCYANIDINS;

EID: 84937399870     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0760-6     Document Type: Article

References (52)

1. MacDermott RP (1996) Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol 31(6):907–916. doi:10.1007/bf02358624
2. Sartor RB (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92(12 Suppl):5S–11S
3. Netsch MI, Gutmann H, Aydogan C, Drewe J (2006) Green tea extract induces interleukin-8 (IL-8) mRNA and protein expression but specifically inhibits IL-8 secretion in caco-2 cells. Planta Med 72(8):697–702. doi:10.1055/s-2006-931597
4. Basu A, Penugonda K (2009) Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 67(1):49–56. doi:10.1111/j.1753-4887.2008.00133.x
5. Mitjavila MT, Moreno JJ (2012) The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases. Biochem Pharmacol 84(9):1113–1122. doi:10.1016/j.bcp.2012.07.017
6. Rasmussen SE, Frederiksen H, Struntze Krogholm K, Poulsen L (2005) Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res 49(2):159–174. doi:10.1002/mnfr.200400082
7. Spencer JP, Chaudry F, Pannala AS, Srai SK, Debnam E, Rice-Evans C (2000) Decomposition of cocoa procyanidins in the gastric milieu. Biochem Biophys Res Commun 272(1):236–241. doi:10.1006/bbrc.2000.2749
8. Rios LY, Bennett RN, Lazarus SA, Rémésy C, Scalbert A, Williamson G (2002) Cocoa procyanidins are stable during gastric transit in humans. Am J Clin Nutr 76(5):1106–1110
9. Deprez S, Mila I, Huneau JF, Tome D, Scalbert A (2001) Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells. Antioxid Redox Signal 3(6):957–967. doi:10.1089/152308601317203503
10. Yoshioka Y, Akiyama H, Nakano M, Shoji T, Kanda T, Ohtake Y, Takita T, Matsuda R, Maitani T (2008) Orally administered apple procyanidins protect against experimental inflammatory bowel disease in mice. Int Immunopharmacol 8(13–14):1802–1807. doi:10.1016/j.intimp.2008.08.021
11. Li XL, Cai YQ, Qin H, Wu YJ (2008) Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis. Can J Physiol Pharmacol 86(12):841–849. doi:10.1139/Y08-089
12. Wang YH, Yang XL, Wang L, Cui MX, Cai YQ, Li XL, Wu YJ (2010) Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats. Can J Physiol Pharmacol 88(9):888–898. doi:10.1139/y10-071
13. Nandakumar V, Singh T, Katiyar SK (2008) Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269(2):378–387. doi:10.1016/j.canlet.2008.03.049
14. Velmurugan B, Singh RP, Kaul N, Agarwal R, Agarwal C (2010) Dietary feeding of grape seed extract prevents intestinal tumorigenesis in APCmin/+ mice. Neoplasia 12(1):95–102. doi:10.1593/neo.91718
15. Edwards K, Kwaw I, Matud J, Kurtz I (1999) Effect of pistachio nuts on serum lipid levels in patients with moderate hypercholesterolemia. J Am Coll Nutr 18(3):229–232. doi:10.1080/07315724.1999.10718856
16. Kocyigit A, Koylu AA, Keles H (2006) Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis 16(3):202–209. doi:10.1016/j.numecd.2005.08.004
17. Sheridan MJ, Cooper JN, Erario M, Cheifetz CE (2007) Pistachio nut consumption and serum lipid levels. J Am Coll Nutr 26(2):141–148. doi:10.1080/07315724.2007.10719595
18. Sari I, Baltaci Y, Bagci C, Davutoglu V, Erel O, Celik H, Ozer O, Aksoy N, Aksoy M (2010) Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: a prospective study. Nutrition 26(4):399–404. doi:10.1016/j.nut.2009.05.023
19. Gentile C, Tesoriere L, Butera D, Fazzari M, Monastero M, Allegra M, Livrea MA (2007) Antioxidant activity of Sicilian pistachio (Pistacia vera L. var. Bronte) nut extract and its bioactive components. J Agric Food Chem 55(3):643–648. doi:10.1021/jf062533i
20. Gentile C, Allegra M, Angileri F, Pintaudi AM, Livrea MA, Tesoriere L (2012) Polymeric proanthocyanidins from Sicilian pistachio (Pistacia vera L.) nut extract inhibit lipopolysaccharide-induced inflammatory response in RAW 264.7 cells. Eur J Nutr 51(3):353–363. doi:10.1007/s00394-011-0220-5
21. Jordão AM, Gonçalves FJ, Correia AC, Cantão J, Rivero-Pérez MD, González Sanjosé ML (2010) Proanthocyanidin content, antioxidant capacity and scavenger activity of Portuguese sparkling wines (Bairrada Appellation of Origin). J Sci Food Agric 90:2144–2152. doi:10.1002/jsfa.4064
22. Porter LJ, Hrstich LN, Chan BG (1985) The conversion of procyanidin and prodelphinidins to cyanidin and delphinidin. Phytochemistry 25:223–230. doi:10.1016/S0031-9422(00)94533-3
23. Tesoriere L, Attanzio A, Allegra M, Gentile C, Livrea MA (2014) Indicaxanthin inhibits NADPH oxidase (NOX)-1 activation and NF-κB-dependent release of inflammatory mediators and prevents the increase of epithelial permeability in IL-1β-exposed Caco-2 cells. Br J Nutr 111(3):415–423. doi:10.1017/S0007114513002663
24. Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A (2000) Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med 28(5):727–738. doi:10.1016/S0891-5849(00)00160-X
25. Tesoriere L, Gentile C, Angileri F, Attanzio A, Tutone M, Allegra M, Livrea MA (2013) Trans-epithelial transport of the betalain pigments indicaxanthin and betanin across Caco-2 cell monolayers and influence of food matrix. Eur J Nutr 52(3):1077–1087. doi:10.1007/s00394-012-0414-5
26. Artursson P (1990) Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal (Caco-2) absorptive cells. J Pharm Sci 79:476–482. doi:10.1002/jps.2600790604
27. Wang D, Dubois RN (2010) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29(6):781–788. doi:10.1038/onc.2009.421
28. Barnes PJ (1997) Nuclear factor-kappa B. Int J Biochem Cell Biol 29(6):867–870. doi:10.1016/S1357-2725(96)00159-8
29. Al-Sadi RM, Ma TY (2007) IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 178(7):4641–4649
30. Walgren RA, Walle UK, Walle T, Wang YH (1998) Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem Pharmacol 55(10):1721–1727. doi:10.1016/S0006-2952(98)00048-3
31. Werner T, Haller D (2007) Intestinal epithelial cell signalling and chronic inflammation: from the proteome to specific molecular mechanisms. Mutat Res 622(1–2):42–57. doi:10.1016/j.mrfmmm.2007.05.010
32. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V (1996) Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38:216–222. doi:10.1136/gut.38.2.216
33. Romier-Crouzet B, Van De Walle J, During A, Joly A, Rousseau C, Henry O, Larondelle Y, Schneider YJ (2009) Inhibition of inflammatory mediators by polyphenolic plant extracts in human intestinal Caco-2 cells. Food Chem Toxicol 47(6):1221–1230. doi:10.1016/j.fct.2009.02.015
34. Duque J, Díaz-Muñoz MD, Fresno M, Iñiguez MA (2006) Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells. Cell Signal 18(8):1262–1269. doi:10.1016/j.cellsig.2005.10.009
35. Wullaert A, Bonnet MC, Pasparakis M (2011) NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res 21(1):146–158. doi:10.1038/cr.2010.175
36. Van De Walle J, Hendrickx A, Romier B, Larondelle Y, Schneider YJ (2010) Inflammatory parameters in Caco-2 cells: effect of stimuli nature, concentration, combination and cell differentiation. Toxicol In Vitro 24(5):1441–1449. doi:10.1016/j.tiv.2010.04.002
37. Erlejman AG, Jaggers G, Fraga CG, Oteiza PI (2008) TNFalpha-induced NF-kappaB activation and cell oxidant production are modulated by hexameric procyanidins in Caco-2 cells. Arch Biochem Biophys 476(2):186–195. doi:10.1016/j.abb.2008.01.024
38. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A (2003) Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171(11):6164–6172
39. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC (2002) Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 34(4):385–396. doi:10.1097/00004836-200204000-00003
40. Erlejman AG, Fraga CG, Oteiza PI (2006) Procyanidins protect Caco-2 cells from bile acid- and oxidant-induced damage. Free Radic Biol Med 41(8):1247–1256. doi:10.1016/j.freeradbiomed.2006.07.002
41. Verstraeten SV, Keen CL, Schmitz HH, Fraga CG, Oteiza PI (2003) Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic Biol Med 34(1):84–92. doi:10.1016/S0891-5849(02)01185-1
42. Williams RJ, Spencer JP, Rice-Evans C (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36:838–849
43. Erlejman AG, Verstraeten SV, Fraga CG, Oteiza PI (2004) The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects. Free Radic Res 38(12):1311–1320. doi:10.1080/10715760400016105
44. Da Silva M, Jaggers GK, Verstraeten SV, Erlejman AG, Fraga CG, Oteiza PI (2012) Large procyanidins prevent bile-acid-induced oxidant production and membrane-initiated ERK1/2, p38, and Akt activation in Caco-2 cells. Free Radic Biol Med 52(1):151–159. doi:10.1016/j.freeradbiomed.2011.10.436
45. Mahe S, Huneau JF, Marteau P, Thuillier F, Tome D (1992) Gastroileal nitrogen and humans. Am J Clin Nutr 56:410–441
46. Fraga CG, Galleano M, Verstraeten SV, Oteiza PI (2010) Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med 31(6):435–445. doi:10.1016/j.mam.2010.09.006
47. Dixon RA, Xie DY, Sharma SB (2005) Proanthocyanidins—a final frontier in flavonoid research? New Phytol 165(1):9–28. doi:10.1111/j.1469-8137.2004.01217.x
48. Ruiz PA, Haller D (2006) Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J Nutr 136(3):664–671
49. Romier B, Van De Walle J, During A, Larondelle Y, Schneider YJ (2008) Modulation of signalling nuclear factor-kB activation pathway by polyphenols in human intestinal Caco-2 cells. Br J Nutr 100:542–551. doi:10.1017/S0007114508966666
50. Sergent T, Piront N, Meurice J, Toussaint O, Schneider YJ (2010) Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. Chem Biol Interact 188(3):659–667. doi:10.1016/j.cbi.2010.08.007
51. Seibel J, Molzberger AF, Hertrampf T, Laudenbach-Leschowski U, Diel P (2009) Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur J Nutr 48(4):213–220. doi:10.1007/s00394-009-0004-3
52. Morimoto M, Watanabe T, Yamori M, Takebe M, Wakatsuki Y (2009) Isoflavones regulate innate immunity and inhibit experimental colitis. J Gastroenterol Hepatol 24(6):1123–1129. doi:10.1111/j.1440-1746.2008.05714.x